Press Room - Sanofi US News

Menu

Media Room Menu

Month Year

Month Year

Jan 18, 2006

FDA grants priority review to PLAVIX® (clopidogrel bisulfate) Supplemental New Drug Application (sNDA) for additional type of heart attack

Filing for STEMI Indication Also Submitted in Europe
Jan 13, 2006

Pfizer to purchase Sanofi-aventis rights to EXUBERA® in application of change of control clauses
Jan 4, 2006

Procter & Gamble Pharmaceuticals and Sanofi-aventis US LLC file lawsuit against Roche Pharmaceuticals and Glaxosmithkline

Lawsuit Alleges Advertising for Once-a-Month Osteoporosis Drug Misleads Physicians and Consumers
Dec 13, 2005

PLAVIX® (clopidogrel bisulfate) recommended as effective cardiovascular risk reduction treatment for patients with established Peripheral Arterial Disease (P.A.D.)
Dec 8, 2005

Interim analysis of phase III study shows TAXOTERE®-based regimens with HERCEPTIN® significantly improved disease free survival in women with early-stage HER2-positive breast cancer
Dec 6, 2005

New analysis ranks America’s worst cities for respiratory infections
Dec 2, 2005

FDA Grants Priority Review to Taxotere® for the Supplemental New Drug Application for Advanced Gastric Cancer
Nov 16, 2005

New England Journal of Medicine publishes the RIO-Lipids study
Nov 15, 2005

Study shows that intra-articular hyaluronate therapy HYALGAN® (sodium hyaluronate) is effective in treating chronic shoulder pain due to osteoarthritis
Nov 15, 2005

Analysis from several clinical studies show dronedarone appears to be consistently safe and effective in maintaining normal sinusal rhythm and ventricular rate control in patients with cardiac arrhythmia

Show per page

Print
Email page
RSS

You are about to leave www.sanofi.us

If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.